Company: ADZCF
Filing Date: 2025-06-27
Form Type: 424B2
Source: 0000950103-25-007986
Chunk: 29

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-06-27
Form: 424B2
Chunk 29
---
22.99 |           $173.29 |
| December 31, 2029         |                $0.00 |                       $23.84 |           $197.13 |
| July 1, 2030              |           $1, 221.05 |                       $23.92 |           $221.05 |

Neither the comparable yield nor the projected
payment schedule constitutes a representation by us regarding the actual amount(s) that we will pay on the Notes.

<div align='center'>PS-22</div>

| Supplemental Plan of Distribution (Conflicts of Interest) |

UBS Financial Services Inc. and its affiliates,
and DBSI, acting as agents for Deutsche Bank AG, will receive or allow as a concession or reallowance to other dealers discounts and commissions
in the amount indicated on the cover hereof. We will agree that UBS Financial Services Inc. may sell all or part of the Notes that it
purchases from us to investors at the price to public indicated on the cover of this pricing supplement, or to its affiliates at the price
to public indicated on the cover of this pricing supplement minus a concession not to exceed the discounts and commissions indicated on
the cover.

We or our affiliates expect to hedge our exposure from the Notes by entering into equity and equity derivative transactions, such as over-the-counter options, futures or exchange-traded instruments with one or more hedge counterparties, which will include UBS or its affiliates. The agent’s discounts and commissions indicated on the cover hereof do not include any profits that UBS, we or any of our or their respective affiliates expect to realize from such hedging activities. See “Selected Risk Considerations”herein for additional considerations
relating to hedging activities.

DBSI, one of the agents for this offering, is our
affiliate. Because DBSI is both our affiliate and a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”),
the underwriting arrangements for this offering must comply with the requirements of FINRA Rule 5121 regarding a FINRA member firm’s
distribution of the securities of an affiliate and related conflicts of interest. In accordance with FINRA Rule 5121, DBSI may not make
sales in this offering of the Notes to any of its discretionary accounts without the prior written approval of the customer. Please see
“Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

| Validity of the Notes |

In the opinion of Davis Polk & Wardwell LLP